Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Epidemiology of Rheumatoid Arthritis May Be Changing

Will Boggs, MD  |  March 3, 2020

NEW YORK (Reuters Health)’Over the last three decades, there has been a significant decline in the incidence of rheumatoid factor (RF) positive rheumatoid arthritis (RA), while the overall incidence of RA has remained about the same, researchers report.

“These trends may suggest changing serological profile of RA over time which may have implications for RA diagnosis and management,” Elena Myasoedova, MD, PhD, of Mayo Clinic, Rochester, Minn., tells Reuters Health by email.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

For their study, published in the Annals of the Rheumatic Diseases, Dr. Myasoedova and colleagues used data from the Rochester Epidemiology Project medical-record-linkage system. Overall, the age-adjusted and sex-adjusted annual incidence of RA per 100,000 in 2005–2014 was 41, with an incidence of 53 in women and 29 in men, estimates that were similar to the previous decades.1

The proportion of RF-positive RA declined significantly from 69% in the earlier decades to 51% in the 2005-2014 group (P<0.001), with a corresponding increase in the proportion of RF-negative RA.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The prevalence of erosive disease remained stable among patients with RF-positive RA while the proportion of erosive disease in RF-negative RA rose in 2005–2014 compared with the prior decades.

“Seronegative RA can be challenging to diagnose, which may delay treatment initiation and negatively impact the outcomes,” Dr. Myasoedova says. “The increasing incidence of RF-negative RA suggests the need for increased awareness and timely recognition of this subset of RA by physicians.”

“Future studies should investigate the underlying reasons for these trends in RA incidence in order to extend understanding of the risk factors for seropositive and particularly for seronegative RA,” she says.


Reference

  1. Myasoedova E, Davis J, Matteson EL, et al. Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985–2014. Ann Rheum Dis. 2020 Feb 17. pii: annrheumdis-2019-216694. [Epub ahead of print]

Share: 

Filed under:ConditionsRheumatoid Arthritis Tagged with:Rheumatoid Arthritis (RA)Rheumatoid Factorseronegative RAseropositive RA

Related Articles

    Seronegative RA May Be on the Rise

    May 25, 2020

    A study comparing trends in the incidence of RA from 2005 to 2014 with previous decades showed a shift in RA subset, suggesting the need for timely recognition of rheumatoid factor-negative RA…

    For RA Patients, Functional Disability May Precede Diagnosis

    September 1, 2020

    In a study, researchers found rheumatoid arthritis patients experience a persistent burden of functional disability regardless of disease duration, age or gender.

    Studies Highlight Risk of Damage from Lupus Treatments

    April 20, 2017

    Marcos Mesa Sam Wordley/shutterstock.com WASHINGTON, D.C.—Conference goers who braved the final day of the 2016 ACR/ARHP Annual Meeting were awarded for their stamina by learning about issues relating to the damage caused by systemic lupus erythematosus (SLE) during the session Systemic Lupus Erythematosus—Clinical Aspects and Treatment V: Damage and Morbidity. Minimizing Damage: Early Use of…

    Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease

    December 1, 2014

    A review of data on antinuclear antibodies and tests for rheumatoid arthritis

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences